Document is current

Any future updates will be listed below

Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol

Crossref DOI link: https://doi.org/10.1007/s12325-018-0708-y

Published Online: 2018-05-25

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark